Home  »  Finance   »  What should you know before buying stock in Oncoru...

What should you know before buying stock in Oncorus Inc. (ONCR)

Oncorus Inc. (NASDAQ: ONCR) is -47.29% lower on its value in year-to-date trading and has touched a low of $11.50 and a high of $37.86 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ONCR stock was last observed hovering at around $16.55 in the last trading session, with the day’s gains setting it 0.49% off its average median price target of $37.50 for the next 12 months. It is also 62.13% off the consensus price target high of $45.00 offered by 4 analysts, but current levels are 45.03% higher than the price target low of $31.00 for the same period.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Currently trading at $17.04, the stock is 19.60% and 14.48% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.26 million and changing 2.96% at the moment leaves the stock -18.58% off its SMA200. ONCR registered a loss of -4.38% in past 6-months. The firm has a 50-day simple moving average (SMA 50) of $15.29 and a 200-day simple moving average (SMA200) of $21.89.

The stock witnessed a 37.64% gain in the last 1 month and extending the period to 3 months gives it a -25.88%, and is 18.01% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.87% over the week and 7.72% over the month.

Distance from 52-week low is 48.17% and -54.99% from its 52-week high.

Oncorus Inc. (ONCR) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Oncorus Inc. (ONCR) is a “Buy”. 4 analysts offering their recommendations for the stock have an average rating of 1.70, where 0 rate it as a Hold and 0 think it is a “Overweight”. 4 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

Oncorus Inc. is expected to release its quarterly report on 09/01/2021 and quarterly earnings per share for the current quarter are estimated at -$0.53.The EPS is expected to shrink by -62.40% this year.

Oncorus Inc. (ONCR) Top Institutional Holders

66 institutions hold shares in Oncorus Inc. (ONCR), with 2.64M shares held by insiders accounting for 10.28% while institutional investors hold 88.25% of the company’s shares. The shares outstanding are 21.78M, and float is at 12.19M with Short Float at 6.59%. Institutions hold 79.17% of the Float.

The top institutional shareholder in the company is MPM Asset Management, LLC with over 2.85 million shares valued at $92.12 million. The investor’s holdings represent 11.12% of the ONCR Shares outstanding. As of Dec 30, 2020, the second largest holder is Deerfield Management Company, L.P. (Series C) with 2.85 million shares valued at $92.11 million to account for 11.12% of the shares outstanding. The other top investors are MPM ONCOLOGY IMPACT MANAGEMENT LP which holds 2.38 million shares representing 9.28% and valued at over $76.85 million, while Perceptive Advisors Llc holds 7.77% of the shares totaling 1.99 million with a market value of $64.34 million.

Oncorus Inc. (ONCR) Insider Activity

A total of 6 insider transactions have happened at Oncorus Inc. (ONCR) in the last six months, with sales accounting for 1 and purchases happening 5 times. The most recent transaction is an insider sale by Queva Christophe, the company’s CSO and SVP, Research. SEC filings show that Queva Christophe sold 17,990 shares of the company’s common stock on Apr 28 at a price of $15.22 per share for a total of $0.27 million. Following the sale, the insider now owns 59175.0 shares.

Oncorus Inc. disclosed in a document filed with the SEC on Apr 27 that Queva Christophe (CSO and SVP, Research) sold a total of 211 shares of the company’s common stock. The trade occurred on Apr 27 and was made at $15.00 per share for $3165.0. Following the transaction, the insider now directly holds 77165.0 shares of the ONCR stock.

Still, SEC filings show that on Apr 26, Queva Christophe (CSO and SVP, Research) disposed off 54 shares at an average price of $15.00 for $810.0. The insider now directly holds 77,376 shares of Oncorus Inc. (ONCR).

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Related Posts




Download Free eBook For

The 5 Best Growth Stocks 2022

100% free. stop anytime no spam